Mural Oncology (MURA) Institutional Ownership $4.05 -0.17 (-4.03%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$4.04 -0.01 (-0.25%) As of 02/21/2025 07:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Mural Oncology (NASDAQ:MURA)CurrentInstitutional OwnershipPercentage80.21%Number ofInstitutional Buyers(last 12 months)25TotalInstitutional Inflows(last 12 months)$14.76MNumber ofInstitutional Sellers(last 12 months)13TotalInstitutional Outflows(last 12 months)$2.64M Get MURA Insider Trade Alerts Want to know when executives and insiders are buying or selling Mural Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MURA Institutional Buying and Selling by Quarter Mural Oncology Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/18/2025 Alpine Global Management LLC80,964$261K0.1%-61.6%0.476% 2/17/2025 Squarepoint Ops LLC175,502$565K0.0%+1.4%1.031% 2/17/2025 Two Sigma Advisers LP26,000$84K0.0%N/A0.153% 2/17/2025 Two Sigma Investments LP65,150$210K0.0%+12.0%0.383% 2/17/2025 Prosight Management LP466,822$1.50M0.4%-18.2%2.743% 2/17/2025 Millennium Management LLC168,255$542K0.0%-11.1%0.989% 2/17/2025 Bridgeway Capital Management LLC29,300$94K0.0%N/A0.172% 2/17/2025 Acorn Capital Advisors LLC1,286,079$4.14M2.3%N/A7.556% 2/14/2025 Jane Street Group LLC21,117$68K0.0%N/A0.124% 2/14/2025 Northern Trust Corp39,966$129K0.0%+22.0%0.235% Get the Latest News and Ratings for MURA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mural Oncology and its competitors with MarketBeat's FREE daily newsletter. 2/14/2025 RBF Capital LLC338,669$1.09M0.1%-5.9%1.990% 2/14/2025 Price T Rowe Associates Inc. MD26,905$87K0.0%-28.6%0.158% 2/14/2025 Alpine Global Management LLC80,964$261K0.1%-61.6%0.476% 2/13/2025 Raymond James Financial Inc.56,176$181K0.0%N/A0.330% 2/13/2025 Renaissance Technologies LLC238,465$768K0.0%+17.4%1.401% 2/12/2025 Geode Capital Management LLC181,029$583K0.0%-4.7%1.064% 2/12/2025 Nicollet Investment Management Inc.94,737$305K0.1%-4.3%0.557% 2/11/2025 Virtu Financial LLC40,025$129K0.0%N/A0.235% 2/6/2025 Raymond James Financial Inc.56,176$181K0.0%N/A0.330% 1/13/2025 FNY Investment Advisers LLC15,000$48K0.0%-25.0%0.088% 11/16/2024 Geode Capital Management LLC190,056$595K0.0%+2.6%1.115% 11/15/2024 RBF Capital LLC359,900$1.13M0.1%-7.3%2.112% 11/15/2024 Point72 Asset Management L.P.108,715$340K0.0%N/A0.638% 11/15/2024 Centiva Capital LP203,706$638K0.0%-9.3%1.195% 11/15/2024 Point72 Asia Singapore Pte. Ltd.12,574$39K0.0%-52.8%0.074% 11/14/2024 Verition Fund Management LLC340,000$1.06M0.0%-33.4%1.996% 11/13/2024 BNP Paribas Financial Markets28,048$88K0.0%-71.0%0.165% 11/13/2024 FMR LLC20,580$64K0.0%+124.7%0.121% 11/9/2024 Primecap Management Co. CA140,045$438K0.0%-40.5%0.822% 11/8/2024 Commerce Bank12,423$39K0.0%N/A0.073% 9/16/2024 Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 9/16/2024 Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/15/2024 Armistice Capital LLC1,688,000$5.30M0.1%N/A9.974% 8/15/2024 Point72 Asia Singapore Pte. Ltd.26,642$84K0.0%N/A0.157% 8/14/2024 Squarepoint Ops LLC167,644$526K0.0%N/A0.991% 8/14/2024 Cubist Systematic Strategies LLC31,243$98K0.0%N/A0.185% 8/13/2024 Canada Pension Plan Investment Board22,360$70K0.0%N/A0.132% 8/9/2024 Primecap Management Co. CA235,551$740K0.0%N/A1.392% 8/9/2024 Renaissance Technologies LLC232,100$729K0.0%N/A1.371% 8/9/2024 Dimensional Fund Advisors LP22,563$71K0.0%N/A0.133% The Real Hillbilly Elegy (Ad)The mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky, Tennessee and beyond… It's one of our country’s most scenic areas. But hidden beneath the beauty is an ugly reality: our most beautiful land is also the poorest. It’s a tragedy because for over 200 years, generation after generation has worked “coal country” with nothing but a pick and shovel, hauling billions of dollars from the ground.A bold new plan, hidden in Executive Order 14154…8/8/2024 Nicollet Investment Management Inc.98,016$308K0.1%N/A0.579% 8/6/2024 Acadian Asset Management LLC318,536$998K0.0%N/A1.882% 8/5/2024 BBR Partners LLC10,000$31K0.0%N/A0.059% 8/1/2024 Rhumbline Advisers10,786$34K0.0%N/A0.064% 7/9/2024 Harbor Capital Advisors Inc.36,769$115K0.0%N/A0.217% (Data available from 1/1/2016 forward) MURA Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MURA shares? During the previous two years, 34 institutional investors and hedge funds held shares of Mural Oncology. The most heavily invested institutionals were Armistice Capital LLC ($5.30M), Acorn Capital Advisors LLC ($4.14M), Prosight Management LP ($1.50M), RBF Capital LLC ($1.09M), Verition Fund Management LLC ($1.06M), Acadian Asset Management LLC ($998K), and Renaissance Technologies LLC ($768K).Learn more on MURA's institutional investors. What percentage of Mural Oncology stock is owned by institutional investors? 80.21% of Mural Oncology stock is owned by institutional investors. Learn more on MURA's institutional investor holdings. Which institutional investors have been buying Mural Oncology stock? Of the 25 institutional investors that purchased Mural Oncology stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Armistice Capital LLC ($1.69M), Acorn Capital Advisors LLC ($1.29M), Acadian Asset Management LLC ($318.54K), Renaissance Technologies LLC ($267.50K), Primecap Management Co. CA ($235.55K), Squarepoint Ops LLC ($170.11K), and Raymond James Financial Inc. ($112.35K). How much institutional buying is happening at Mural Oncology? Institutional investors have bought a total of 4,662,323 shares in the last 24 months. This purchase volume represents approximately $14.76M in transactions. Which Mural Oncology major shareholders have been selling company stock? Of the 13 institutional investors that sold Mural Oncology stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Alpine Global Management LLC ($259.25K), Verition Fund Management LLC ($170.85K), Prosight Management LP ($103.80K), Primecap Management Co. CA ($95.51K), BNP Paribas Financial Markets ($68.69K), RBF Capital LLC ($49.47K), and Millennium Management LLC ($20.96K). How much institutional selling is happening at Mural Oncology? Institutional investors have sold a total of 832,438 shares in the last 24 months. This volume of shares sold represents approximately $2.64M in transactions. Related Companies Voyager Therapeutics Institutional Ownership Neumora Therapeutics Institutional Ownership Immutep Institutional Ownership enGene Institutional Ownership Candel Therapeutics Institutional Ownership Kodiak Sciences Institutional Ownership Neurogene Institutional Ownership Rezolute Institutional Ownership Y-mAbs Therapeutics Institutional Ownership DiaMedica Therapeutics Institutional Ownership This page (NASDAQ:MURA) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersThe Real Hillbilly ElegyThe mountains of Appalachia are incredible to behold. Spanning thousands of miles across Alabama, Kentucky...Porter & Company | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored$5,000 DOGE check?Elon Musk's DOGE agenda just took a very surprising turn... Earlier this week, reports emerged that a porti...Altimetry | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | Sponsored2025 AI Blueprint features Nvidia’s march to $5 trillionNvidia is now one of the most valuable companies in the world. It currently ranks second, just behind Apple...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendThere's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a tra...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mural Oncology plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Mural Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
